Ticker: RMTI

Rockwell Medical, Inc. (NASDAQ: RMTI) - Q2 2025 snapshot Quick take * Revenue is sliding sharply after losing material volume from a major customer (DaVita). * Management says liquidity is sufficient for at least 12 months, but the company still depends on access to capital (ATM facility) and exe...

Rockwell Medical, Inc. (NASDAQ: RMTI) has reported its financial results for the first quarter of 2025, revealing both challenges and areas for potential improvement as it continues its focus on the hemodialysis market. Key Financial Highlights: Net Sales: $18.9 million for Q1 2025, down 17% fro...